| MRSH |
Report |
Consolidated underlying revenue growth |
BEAT |
pred ~3.9% vs. cons 3.6% |
MEDIUM |
| MRSH |
Report |
Risk & Insurance Services underlying revenue growth |
BEAT |
pred ~3.4% vs. cons 3.1% |
MEDIUM |
| MRSH |
Report |
Adjusted EPS |
BEAT |
pred ~$2.96 vs. cons $2.90 |
MEDIUM |
| MRSH |
Guide |
FY2026 consolidated underlying revenue-growth outlook / insurance-pricing commentary |
LOWER |
guide ~3.5% vs. cons 3.6% (FY2026) |
MEDIUM |
| MRSH |
Guide |
FY2026 adjusted EPS outlook |
BETTER |
guide ~$11.65 vs. cons $11.50 (FY2026) |
LOW |
| MRSH |
Guide |
FY2026 adjusted operating-margin outlook |
BETTER |
guide ~30.0% vs. cons 29.8% (FY2026) |
MEDIUM |
| MRSH |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.7% |
— |
MEDIUM |
| MRSH |
Return |
5-day cumulative residual |
+2.4% (FOLLOW-THROUGH) |
pred ~3.9% underlying growth vs. cons 3.6% and pred ~$2.96 EPS vs. cons $2.90 should support modest upward FY2026 revisions despite guide ~3.5% growth vs. cons 3.6%, because margin guide ~30.0% vs. cons 29.8% preserves out-period EPS leverage. |
MEDIUM |